Literature DB >> 33422457

European Association of Urology Guidelines Panel on Male Sexual and Reproductive Health: A Clinical Consultation Guide on the Indications for Performing Sperm DNA Fragmentation Testing in Men with Infertility and Testicular Sperm Extraction in Nonazoospermic Men.

Tharu Tharakan1, Carlo Bettocchi2, Joana Carvalho3, Giovanni Corona4, Thomas Hugh Jones5, Ates Kadioglu6, Juan I Martínez Salamanca7, Ege Can Serefoglu8, Paolo Verze9, Andrea Salonia10, Suks Minhas11.   

Abstract

Accumulating evidence has highlighted the contribution of oxidative stress and sperm DNA fragmentation (SDF) in the pathophysiology of male infertility. SDF has emerged as a novel biomarker of risk stratification for patients undergoing assisted reproductive technologies. Studies have also supported the use of testicular over ejaculated sperm at the time of intracytoplasmic sperm injection, as testicular sperm may have lower SDF than ejaculated samples. The European Association of Urology Working Panel on Male Sexual and Reproductive Health provides an evidence-based consultation guide on the indications for SDF testing in male infertility and also for testicular sperm extraction (TESE) in nonazoospermic men. We present the limitations and advantages of SDF testing and a framework to ensure that it is appropriately utilised in clinical practice. Furthermore, we critically appraise the current literature advocating the use of TESE in nonazoospermic men. PATIENT
SUMMARY: This article reviews the evidence supporting the use of sperm DNA fragmentation testing in the assessment of male infertility and testicular sperm extraction in nonazoospermic men.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technologies; Male infertility; Sperm DNA fragmentation; Testicular sperm extraction

Mesh:

Year:  2021        PMID: 33422457     DOI: 10.1016/j.euf.2020.12.017

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  5 in total

Review 1.  The impact of male factors and their correct and early diagnosis in the infertile couple's pathway: 2021 perspectives.

Authors:  F Pallotti; A Barbonetti; G Rastrelli; D Santi; G Corona; F Lombardo
Journal:  J Endocrinol Invest       Date:  2022-03-29       Impact factor: 5.467

2.  Semen Analysis of Total Motile Sperm Count Based on the 1999 and 2010 WHO Criteria.

Authors:  Patrícia de Moraes De Zorzi; Ana Paula de Souza Kussler; Anita Mylius Pimentel; Edison Capp; Helena von Eye Corleta
Journal:  JBRA Assist Reprod       Date:  2022-04-17

Review 3.  Microsurgical Management of Male Infertility: Compelling Evidence That Collaboration with Qualified Male Reproductive Urologists Enhances Assisted Reproductive Technology (ART) Outcomes.

Authors:  Jessica Marinaro; Marc Goldstein
Journal:  J Clin Med       Date:  2022-08-06       Impact factor: 4.964

4.  The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 thresholds for normal semen parameters?

Authors:  Luca Boeri; Giuseppe Fallara; Edoardo Pozzi; Federico Belladelli; Christian Corsini; Massimiliano Raffo; Nicolò Schifano; Paolo Capogrosso; Alessia d'Arma; Francesco Montorsi; Andrea Salonia
Journal:  Andrology       Date:  2022-06-30       Impact factor: 4.456

Review 5.  Sperm DNA Fragmentation: A Critical Assessment of Clinical Practice Guidelines.

Authors:  Ashok Agarwal; Ala'a Farkouh; Neel Parekh; Armand Zini; Mohamed Arafa; Hussein Kandil; Nick Tadros; Gian Maria Busetto; Rafael Ambar; Sijo Parekattil; Florence Boitrelle; Hassan Sallam; Sunil Jindal; Edmund Ko; Mara Simopoulou; Hyun Jun Park; Mohammad Ali Sadighi; Ramadan Saleh; Jonathan Ramsay; Marlon Martinez; Haitham Elbardisi; Juan Alvarez; Giovanni Colpi; Jaime Gosalvez; Donald Evenson; Rupin Shah
Journal:  World J Mens Health       Date:  2021-04-21       Impact factor: 5.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.